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Abstract LDL particle size can be measured by gradient
gel electrophoresis (GGE) and NMR. The agreement be-
tween the two methods has not been extensively evaluated.
Therefore, we measured LDL size by NMR and GGE in 324
individuals (152 with type 1 diabetes and 172 controls). The
Spearman correlation between both methods was 0.39 [95%
confidence interval (CI) 
 

 
 0.29, 0.48]. The average differ-
ence was 5.38 nm (NMR being smaller), but it increased with
increasing LDL size. Less than 50% of people classified as
 
pattern B on GGE were classified as pattern B on NMR (
 

 
 
 

 
0.31; 95% CI 
 

 
 0.17, 0.45). Agreement was lower for dia-
betic subjects compared with controls, for women com-
pared with men, and for subjects with triglycerides less than
1.30 mmol/l compared with subjects with triglycerides
greater than 1.30 mmol/l. External validation showed that
cholesteryl ester transfer rate was related to LDL size on
GGE in all subgroups and to LDL size on NMR only in men
and nondiabetic subjects.  Our findings show that agree-
ment between NMR- and GGE-based LDL size is far from
perfect and is not consistent across subgroups of patients.
In particular, the two methods should not be assumed to be
interchangeable in women and diabetic subjects. Whether
NMR or GGE predicts cardiovascular disease risk better
has not yet been evaluated.
 
—Witte, D. R., M. R. Taskinen,
H. Perttunen-Nio, A. van Tol, S. Livingstone, and H. M. Col-
houn. 
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One of the main current objectives in cardiovascular
risk management is to improve risk prediction. It has be-
come clear that information on lipoprotein subclass in ad-
 
dition to total lipid concentration may be of value in de-
termining the level of risk (1–7).
LDL and HDL particle size and subclass distribution are
determined by a number of metabolic steps, including the
exchange of cholesteryl esters from LDL and HDL with
triglycerides from VLDL under the influence of choles-
teryl ester transfer protein (CETP) (8). It has previously
been shown that small, dense LDLs are rich in triglycer-
ides (9). Triglyceride-rich lipoproteins are remodeled by
hepatic lipase, which hydrolyzes triglycerides, resulting in
the specific LDL subspecies (10, 11). Although LDL parti-
cle size is known to be highly associated with the level of
triglycerides (2, 12, 13), there is evidence that the associa-
tion between LDL particle size and cardiovascular risk is
independent of the baseline level of triglycerides (3–5,
12). Therefore, estimation of LDL size has been advo-
cated as a component of cardiovascular disease risk pre-
diction. A small LDL size is considered particularly indica-
tive of risk when the absolute number of LDL particles is
high (14).
A number of methods for the assessment of lipoprotein
size exist, the most widely used being gradient gel electro-
phoresis (GGE) (15) and proton NMR spectroscopy (16,
17). GGE separates LDL particles based on the principle
that particles migrate through the gradient gel until their
further penetration into the gradient is restricted by their
size and to a lesser extent by their charge (18). NMR spec-
troscopy measures the signal emitted by plasma lipid
methyl groups during magnetic resonance scanning (16).
Based on empirically measured signal amplitudes of puri-
fied VLDL, LDL, and HDL subclasses, this method distin-
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guishes the component peaks associated with lipoprotein
subclasses. These subclass signal amplitudes are then re-
garded as a direct measure of the levels of subclass parti-
cles (17).
Despite the broad application of both methods, very
few data on the agreement between the two for LDL size
measurement have been published. The only published
information is based on a small group of healthy middle-
aged men (6). Better insight into the level of agreement
between the two methods is of particular importance in
view of the increasing application of LDL particle size in
both research and clinical practice. The data derived from
LDL size measurements by NMR and GGE are currently
assumed to be interchangeable (14). However, evidence
that this is the case and that this is generally true is lack-
ing. Therefore, we set out to evaluate the agreement be-
tween LDL particle size measured by NMR and peak LDL
size measured by GGE in patients with type 1 diabetes
mellitus and healthy controls.
METHODS
 
Subjects
 
The study population has previously been described in detail
(19–21). It consisted of a random sample of 199 men and women
with type 1 diabetes mellitus, aged 30–55 years, and a random
sample of 201 control subjects from the general population strat-
ified to have a similar age and gender distribution to the patients
with diabetes. Ethics Committee approval was obtained, and all
participants gave fully informed written consent before participa-
tion, having received full details of the study procedures.
Individuals with unavailable data on LDL size from NMR (n 
 

 
7) or GGE (n 
 

 
 59), and those with nonfasting triglyceride sam-
ples (n 
 

 
 9) or fasting triglyceride levels 
 

 
 6.0 mmol/l (n 
 

 
 3),
were excluded from analyses, yielding a study population of 324
individuals (152 with type 1 diabetes mellitus and 172 controls).
Medication use was low in the study population, with 91% of par-
ticipants using no medication (excluding insulin use in all dia-
betic participants). A higher proportion of diabetic patients
compared with controls used antihypertensive medication (11%
and 3%, respectively; 
 
P
 
 
 

 
 0.01), whereas differences in other
drugs were nonsignificant. The use of antihypertensive medica-
tion was not related to either GGE- or NMR-based LDL size, and
the exclusion of patients using medication did not materially al-
ter the findings.
 
Laboratory methods
 
Blood samples were collected between March 1998 and March
1999. After an overnight fast, blood samples were taken from pa-
tients and total cholesterol, HDL cholesterol, and triglycerides
were measured using standard enzymatic colorimetric methods.
Lipoprotein subclass levels were measured on freshly thawed fro-
zen specimens (0.5 ml) that had been frozen at 
 

 
70
 

 
C immedi-
ately after collection and had never been thawed before. Several
separate tubes of plasma were frozen from each patient, and a
separate tube was unfrozen for NMR and another for GGE. Sam-
ples were shipped on dry ice and analyzed immediately after
thawing.
NMR measurements were performed after an average freez-
ing time of 9 months using a 400 megahertz proton NMR ana-
lyzer at LipoScience, Inc. (Raleigh, NC). The detailed methods
of these analyses have been previously described (22, 23). In
short, spectra for each plasma sample were acquired and decon-
voluted to give the amplitudes of the contributing signals. Using
empirically measured relations between lipid contents and signal
amplitudes of purified LDL subclass standards, conversion fac-
tors were derived to transform NMR subclass signal amplitudes
into subclass particle levels (units of nanomoles per liter). Three
LDL subclasses can thus be distinguished: L3 (21.3–23 nm;
mean, 22 nm), L2 (19.8–21.2 nm; mean, 20.5 nm), and L1
(18.3–19.7 nm; mean, 19 nm). LDL size is expressed as the lipid
mass-weighted average particle diameter in nanometers. The
corporate documentation provided by LipoScience (14) states
that LDL subclass diameters are uniformly 
 

 
5 nm smaller than
those estimated by GGE and that an average LDL particle size of
 

 
20.5 nm on NMR is equivalent to pattern B on GGE.
GGE measurements were executed in two batches according
to an identical laboratory protocol. The first batch (n 
 

 
 70) was
measured on average 14 months after collection, and the second
batch (n 
 

 
 254) was measured on average 38 months after col-
lection. The distribution according to sex and diabetes status was
similar in both batches: 52% male and 52% with diabetes in the
first batch, 47% male and 45% with diabetes in the second batch.
The average LDL peak size from both batches and the respective
standard deviations did not differ: 26.49 nm, SD 0.92 nm and
26.41 nm, SD 0.96 nm for the first and second batches, respec-
tively. A comparison of the main results by GGE batch is given in
the online supplemental data.
LDL peak particle size on GGE was determined using 1 mm
thick 2–10% nondenaturing polyacrylamide linear gradient gels.
Reagents (acrylamide-bisacrylamide, Tris, glycine, sucrose, am-
monium persulfate, and tetramethylenediamine were obtained
from Bio-Rad (Hercules, CA). The vertical slab gels were run in
the Bio-Rad Mini-Protean II Electrophoresis Cell. After electro-
phoresis, gels were stained with newly prepared Sudan Black B
lipid stain (Merck, Whitehouse Station, NJ), destained, and
dried. Dried gels were photographed with a Kodak Digital Sci-
ence DC120 camera and analyzed with Amersham Pharmacia
Biotech’s ImageMaster 1D software. Two isolated LDL samples
were used as the size standard on each gel. The sample LDL ma-
jor peak diameter (LDL size) was determined by comparing the
mobility of the sample with the mobility of the two standard LDL
preparations run on each gel. Details of the GGE method used
have been described elsewhere (24).
Plasma cholesteryl ester transfer rate (CET) was measured as
the rate of cholesteryl ester transfer out of HDL into VLDL plus
LDL during incubation of plasma in vitro, that is, measured with
the endogenous lipoprotein substrates using the method of
Channon et al. (25) modified as described by Dullaart et al. (26).
The rate of CET is expressed in nanomoles of cholesteryl ester
transferred per milliliter of plasma per hour and is constant dur-
ing 3 h of incubation. CET is strongly related to the level of
plasma VLDL triglycerides (27).
 
Reproducibility
 
Within-laboratory reproducibility was good for both NMR and
GGE. For GGE, the within-subject coefficients of variation in
those with low, normal, and high triglycerides were 0.99, 1.30,
and 1.92%, respectively (based on 26 repeated measurements in
three individuals), and an overall between-gel coefficient of vari-
ation of 1.4% has been previously reported (24). For NMR the
Spearman correlation for duplicate measurements in 22 individ-
uals in our study population was 0.92. Previously, a coefficient of
variation of 0.5% was reported for 20 replicate measurements of
two plasma pools (23). Currently, the method for gradient gel
electrophoresis is not standardized. Some gradient gels are com-
mercially available but vary in quality. Therefore, many laborato-
ries develop their own, potentially leading to unsatisfactory inter-
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laboratory agreement in the GGE measurement. Interlaboratory
agreement is not an issue in the case of NMR, because Lipo-
Science is the only facility currently performing these measure-
ments.
 
Statistical analysis
 
Analyses were carried out with the Stata statistical package,
version 7. We examined the relation between the average LDL
size measurement on NMR and the peak LDL size on GGE, cal-
culating Spearman’s rho for the group as a whole and for sub-
groups according to gender, the presence of diabetes mellitus,
and tertiles of triglycerides. Analyses in subgroups of gender and
diabetes were repeated in the highest tertile of triglycerides to
exclude the effect of low triglyceride values.
The individual differences between the two methods were cal-
culated and plotted against the mean of both measurements, as
described by Bland and Altman (28). This method enables the
assessment of the presence of bias when the difference between
two methods is not equal across increasing mean levels of the pa-
rameter under study. To further clarify the observed differences
between LDL size measured by NMR and GGE, we modeled the
relation between the difference and the mean of both measure-
ments using linear regression.
The categorical classification of individuals as having pattern
B (LDL size of 
 

 
20.5 nm on NMR and 
 

 
25.5 on GGE) was com-
pared in a two-by-two table. The 
 

 
 statistic, 95% confidence inter-
val (CI), and percentage agreement were calculated using the
DAG Stat diagnostic and agreement statistics spreadsheet (29)
for the group as a whole and for the same subgroups as men-
tioned above. Analyses of the classification as pattern B were re-
peated in subjects with LDL particle numbers greater than 1,400
to assess agreement in the subset of patients for whom LDL size
measurements were clinically most relevant according to the def-
inition by LipoScience (14).
The external validity of both measurements was evaluated by
assessing the relation of LDL size by both methods with CET.
The CET measurement assesses the rate of transfer of cholesteryl
ester from HDL to apolipoprotein B-containing lipoproteins, a
process catalyzed by CETP (8). Plasma CETP activity yields tri-
glyceride-rich LDL particles, which are subsequently remodeled
by hepatic lipase, yielding small, dense LDL particles. Observed
LDL size can thus be considered to depend partly on CET (30),
and an inverse relation between CET and LDL (24, 31) size is to
be expected. Therefore, comparison of the strength of the rela-
tion between CET and LDL size according to NMR and GGE can
be considered a measure of external validity. The relation be-
tween CET and LDL size was assessed using Spearman correla-
tions.
 
RESULTS
The mean difference between LDL size on NMR and
peak LDL size on GGE was 5.38 nm (with NMR being
smaller). The 95% limits of agreement at this point were
3.97 and 6.79, indicating that 95% of the differences be-
tween the two methods can be expected to fall within this
range. The Bland-Altman plot shown in 
 
Fig. 1
 
 indicates
that the absolute difference between the two methods in-
creases with increasing average LDL size. The linear re-
gression line shown in the figure deviated significantly
from a horizontal line (
 
P
 
 
 

 
 0.001). Log transformation as
proposed by Bland and Altman (28) did not alter these
findings.
 
Figure 2
 
 shows the univariate relation between LDL size
as determined by NMR and GGE. The Spearman rank
correlation between the two methods was 0.39 (95% CI 
 

 
0.29, 0.48). The diagonal line of identity indicates where
the points would be expected in the case of perfect agree-
ment, assuming that values on NMR are uniformly 5 nm
smaller than values on GGE, as indicated by LipoScience
(14). Regression analysis showed that a model including a
quadratic term (
 
R
 
2
 
 
 

 
 0.25) was significantly better (
 
P
 
 
 

Fig. 1. Bland-Altman plot with a regression-based estimate for the difference in LDL size according to
NMR and gradient gel electrophoresis (GGE).
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0.0001) than a linear model (
 
R
 
2
 
 
 

 
 0.18) in describing the
relation between the two methods. The quadratic model
line demonstrates that the relation between the two meth-
ods is mostly confined to small LDL sizes and is almost ab-
sent for large LDL sizes.
The difference and the strength of the relation between
LDL size according to NMR and GGE were also different
across different subgroups of the study population. As
shown in 
 
Table 1
 
, the mean difference was larger for pa-
tients with diabetes, women, and those with lower triglyc-
eride levels. Agreement, expressed as the Spearman rho,
was considerably higher in nondiabetic subjects, in men,
and in those with high triglycerides, with estimates for all
groups lying outside the confidence interval of their re-
spective comparison group. In subjects with triglyceride
levels of less than 0.87 mmol/l (the lowest tertile), the two
methods were unrelated. To assess whether the observed
differences in agreement could be explained simply by
the lack of agreement at low triglyceride levels, we re-
peated the analyses in the highest tertile (
 

 
1.30 mmol/l;
n 
 

 
 107). Spearman correlations were 0.47 (0.18, 0.69)
for women, 0.67 (0.52, 0.79) for men, 0.52 (0.26, 0.71) for
subjects with diabetes, and 0.68 (0.51, 0.79) for controls.
 
Table 2
 
 displays the number of subjects who were classi-
fied as having pattern B on NMR and GGE. Forty-eight
percent of subjects classified as having pattern B on GGE
were classified in the same category by NMR. Inversely,
36% of subjects classified as having pattern B on NMR
were classified as pattern B on GGE. 
 
Table 3
 
 shows how
observed agreement and the 
 

 
 statistic differ across sub-
groups of patients. Agreement was considerably higher in
subjects without diabetes, men, and subjects in the highest
tertile of triglycerides. Restriction of analyses to the clini-
cally most relevant group of patients [LDL particle num-
ber 
 

 
 1,400 (14)] showed slightly higher agreement in all
groups, but agreement continued to be lower in women
compared with men and in those with diabetes compared
with controls.
 
Table 4
 
 shows the relation between LDL size according
to both methods and CET for the total group and sub-
groups. In the case of GGE, the relation for all subgroups
is similar to the overall relation, whereas in the case of
NMR, a relation between LDL size and CET is present in
men and in nondiabetic subjects but is absent in women
and in subjects with diabetes.
DISCUSSION
This study found that agreement between LDL size
measured by NMR and GGE is moderate, with consider-
able differences across subgroups of patients. Agreement
in women, patients with diabetes, and patients with low tri-
glyceride levels is considerably lower than agreement in
men, controls without diabetes, and patients with high tri-
glyceride levels, respectively. Differences in triglyceride
Fig. 2. Scatterplot showing the relation between LDL particle size
measured with GGE and NMR. The line of identity is based on the
assumption of values on NMR being uniformly 5 nm smaller than
those on GGE. Model equations are as follows: linear, NMR  14.23 	
(0.26 
 GGE); quadratic, NMR  49.43 	 (5.14 
 GGE) 	
(0.094 
 GGE2).
 
TABLE 1. Comparison of LDL peak size from GGE and LDL size from NMR
 
Difference between NMR and GGE N
Mean 
Difference
95% Limits of
Agreement
Spearman’s
Rho 95% CI
 
nm
 
Complete group 324 5.38 (3.63, 7.13) 0.39 (0.29, 0.48)
By diabetes
Diabetes 152 5.49 (3.68, 7.31) 0.27 (0.11, 0.41)
No diabetes 172 5.27 (3.60, 6.96) 0.51 (0.39, 0.61)
By gender
Men 156 5.20 (3.53, 6.86) 0.52 (0.40, 0.63)
Women 168 5.55 (3.68, 7.41) 0.23 (0.08, 0.36)
By triglyceride tertile
Low (
 

 
0.87) 108 5.73 (3.92, 7.54)
 

 
0.03 (
 

 
0.21, 0.17)
Medium (0.87–1.30) 109 5.41 (3.89, 6.94) 0.29 (0.11, 0.45)
High (
 

 
1.30) 107 4.99 (3.37, 6.61) 0.60 (0.47, 0.71)
CI, confidence interval; GGE, gradient gel electrophoresis.
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distributions do not seem to explain the difference in
agreement between subjects with and without diabetes
and account for only a limited degree of the difference in
agreement between men and women.
Consistent with this, we found that the agreement of
NMR and GGE in distinguishing pattern A from pattern B
was limited in women and diabetic subjects both in the
complete study population and in the subset with large
numbers of LDL particles, in whom the clinical utility of
LDL size measurements is greatest. External validation
showed that the expected inverse relation with CET was
more consistent across subgroups for GGE than for NMR.
 
Importance of these findings
 
It would be naïve to expect perfect agreement between
LDL size according to GGE and NMR given the different
physical features of LDL particles each method is based
on. Whereas GGE results depend directly on the particle
dimensions and charge, NMR results are calculated from
a measurement of the contents of the particle. Further-
more, comparing average particle size on NMR with peak
particle size on GGE is akin to comparing a mean and a
mode. Nevertheless, both methods are currently assumed
to be more or less interchangeable and are widely used
both in research and in clinical practice on this assump-
tion. The cutoff point for the distinction between pattern
A (low risk) and pattern B (high risk) (32) and most of
the prospective evidence for a relation between LDL size
and cardiovascular risk stem from studies based on the
GGE method (2–5). Recently, a relation between LDL size
and the angiographic progression of coronary artery dis-
ease has been found based on GGE measurements from
the same facilities used in the present study (33). One
prospective study has confirmed a relation with cardiovas-
cular risk with the NMR method (6). The only currently
available data on agreement between average LDL size
measured by NMR and peak LDL size on GGE were in a
report on LDL size in the Women’s Health Study (6). The
study population for the agreement section consisted of
21 healthy middle-aged men. A correlation coefficient of
0.86 was reported, but no information was given on the
linearity of the relation, the distribution of the differ-
ences, the distinction between pattern A and pattern B, or
on agreement in women. In conjunction with our results,
this indicates that although the assumption of inter-
changeability may be broadly reasonable in hypertriglyc-
eridemic men, it is not reasonable in women or diabetic
subjects. It might be argued that this disagreement is
more important for research than for clinical uses.
 
Potential limitations
 
Frozen storage has the potential to cause alterations to
lipoproteins (34). The effect on the results of our study,
however, can be expected to be small. There is evidence
that a single freeze-thaw cycle and storage at 
 

 
80
 

 
C does
not affect LDL peak particle diameter on GGE after 3
(35) to 6 (36) months of storage. Furthermore, any
changes attributable to freezing can be assumed to be ran-
domly distributed across individuals and subgroups. Con-
sequently, freezing may lead to effect dilution but it can-
not lead to the introduction of spurious relations. We
found that the duration of sample freezing did not affect
average LDL size: the average LDL size on GGE and its
standard deviation were close to identical for the samples
measured in the first and second GGE batches, which dif-
fered in freezing time by 2 years on average.
The principal finding of this report pertains to the
marked differences in agreement across subgroups. Be-
cause differences in freezing duration were equally present
in all subgroups, freezing cannot explain the observed
subgroup differences in agreement. To substantiate this,
we repeated the statistical analyses by duration of sample
freezing (i.e., GGE batch). Both batches showed the same
pattern of agreement differences: agreement was better in
men compared with women and better in nondiabetic
 
TABLE 2. Two-by-two table of the classification of individuals as 
having pattern B according to GGE and NMR with their respective 
cutoff levels
 
Pattern B on GGE
(peak particle size 
 

 
25.5 nm)
No Yes Total
 
Pattern B on NMR
(average particle size 
 

 
20.5 nm)
No
 
250
 
21 271
Yes 34
 
19
 
53
Total 284 40 324
Boldface values indicate cases in which both methods agree.
TABLE 4. Spearman correlations for the relation between cholesteryl 
ester transfer rate and LDL size according to NMR and GGE across 
subgroups
 
Variable LDL Peak Size on GGE LDL Average Size on NMR 
Rho 95% CI Rho 95% CI
 
Total group
 

 
0.48 
 

 
0.55, 
 

 
0.39
 

 
0.06
 

 
0.16, 0.04
By gender
Men
 

 
0.51 
 

 
0.62, 
 

 
0.38
 

 
0.20
 

 
0.35, 
 

 
0.04
Women
 

 
0.41 
 

 
0.53, 
 

 
0.27 0.02
 

 
0.13, 0.18
By diabetes
Diabetes
 

 
0.46 
 

 
0.58, 
 

 
0.33 0.05
 

 
0.11, 0.21
No diabetes
 

 
0.47 
 

 
0.58, 
 

 
0.35
 

 
0.26
 

 
0.39, 
 

 
0.11
 
TABLE 3. Agreement and 
 

 
 statistics for the agreement in classification 
of patients as pattern B across subgroups according to diabetes
mellitus, gender, and triglyceride levels
 
Variable
Observed Agreement 
(95% CI)
 

 
 (95%CI)
 
Total group 0.83 (0.78, 0.87) 0.31 (0.17, 0.45)
By diabetes
Diabetes 0.78 (0.71, 0.85) 0.16 (
 

 
0.02, 0.34)
No diabetes 0.87 (0.81, 0.92) 0.47 (0.28, 0.66)
By gender
Men 0.79 (0.72, 0.85) 0.36 (0.18, 0.54)
Women 0.87 (0.81, 0.92) 0.15 (
 

 
0.06, 0.36)
By triglyceride level
Low (
 

 
0.87) 0.86 (0.78, 0.92) 0.05 (
 

 
0.17, 0.27)
Medium (0.87–1.30) 0.86 (0.78, 0.92) 0.06 (
 

 
0.16, 0.27)
High (
 

 
1.30) 0.77 (0.67, 0.84) 0.42 (0.22, 0.61)
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controls compared with diabetic subjects. Furthermore,
the relation between GGE and CET was stronger than the
relation between NMR and CET in both batches (data
presented in the online supplemental data). Thus, we
would have arrived at the same conclusions had we limited
our study to the 70 individuals with the shortest freezing
time. The confirmation of our findings in those with longer
freezing time allowed us to regard both batches jointly
and to present the results for the full study population.
It is furthermore important to be aware that the evi-
dence for LDL size as a cardiovascular risk predictor, and
for the cutoff level for pattern B itself, stems from samples
with considerably longer freezing time than in our study
[ranging from 3 to 15 years (2–4, 6)]. Therefore, our find-
ings are applicable and relevant to all situations in which
the evidence of these studies is used in research and clini-
cal practice.
It is important to ascertain whether our findings of dif-
ferences in agreement between men and women, and be-
tween subjects with and without diabetes, are solely attrib-
utable to poor agreement in subjects with low triglyceride
levels. We found that generally in patients with triglycer-
ide levels greater than 1.30 mmol/l, agreement was better
than in the total group. Importantly, however, the differ-
ences in agreement between men and women, and between
those with and without diabetes, remained. This means
that overrepresentation of individuals with low triglycer-
ide levels among women and diabetic patients cannot ex-
plain the differences in agreement between men and
women and between subjects with and without diabetes.
Furthermore, we examined whether our analyses in
subgroups could have led to selection of groups with very
narrow distributions of LDL size, which could affect the
correlations within those groups. Comparison of the LDL
size distributions, according to both methods, showed that
the LDL size distribution in women was somewhat nar-
rower than that in men. However, the distributions did
not differ between subjects with and without diabetes
within each gender. This means that a narrower distribu-
tion might partially account for the difference in agree-
ment between men and women but not for the difference
in agreement between diabetic subjects and controls.
Agreement between NMR and GGE
Our study confirmed that on average NMR yields values
5 nm smaller (5.38 in our data) than GGE, as indicated by
LipoScience (14). However, this average difference can-
not be applied uniformly in practice, because it becomes
considerably larger with increasing LDL size. The 95%
limits of agreement, defining the range within which most
differences are expected to lie, show a band of 3 nm
width. The range for expected differences thus covers ap-
proximately half the range of the LDL size measurement
itself. The sources of this difference remain largely un-
clear, because both methods have initially been calibrated
against cryo-electron microscopy (18, 37). A potential ex-
planation might be found in differences in LDL parti-
cle charge. Particle charge increases with increasing LDL
size (38), possibly influencing the migration of particles
through the gradient gel. It has recently been proposed
that LDL particles have a discoid rather than a spherical
shape and that particle height is primarily determined by
core lipids, whereas diameter is determined by surface
free cholesterol (39). This observation may mean that the
assumption of a spherical shape used in the derivation of
LDL particle size from NMR signals is a potential source
of the agreement differences reported in our study.
Methods can only be considered interchangeable if the
differences between them are small (i.e., the methods are
strongly related) and distributed randomly (i.e., there is
no bias present). This study has shown that for LDL size
according to NMR and GGE, neither condition is met. We
found an overall Spearman rank correlation of 0.39,
which can be considered poor for two methods assessing
the same entity. The best-fitting model for the relation be-
tween both methods was a quadratic one. In this model,
25% of the variation in NMR LDL size was explained by
GGE LDL peak size, which again is too low for two mea-
sures to be considered interchangeable. Furthermore, the
model curve showed that the relation between the two
methods is confined to small LDL sizes and is almost ab-
sent when LDL size is large.
Distinction between pattern A and pattern B
An important clinical cutoff point is the distinction be-
tween pattern A (large LDL) and pattern B (small LDL).
Two methods exist for making this classification. A patient
can be classified as having pattern B if the peak particle
size (GGE) or average particle size (NMR) is below the
threshold of 25.5 or 20.5 nm, respectively. Alternatively, a
patient can be classified as having pattern B if the majority
of LDL particles are below the threshold. In other words,
the first method uses a summary measure for the distri-
bution (peak size or average size), whereas the second
method uses the area under the distribution curve. In this
article, we have used the former method, which is most
common in clinical practice. Our observation that the av-
erage difference between the two methods increases with
increasing LDL size makes it clear that the assumption
that LDL size of 20.5 nm on NMR is equivalent to LDL
size of 25.5 nm on GGE as a determinant of pattern B is
not valid for all patients.
When examining agreement, it is important to differen-
tiate between observed agreement and chance-adjusted
agreement (). The observed agreement depends heavily
on the underlying frequencies. Because pattern A is much
more common than pattern B (85% and 15%, respec-
tively, in our data), in 75% of patients both methods
would be expected to agree by chance alone. Therefore, a
method should be evaluated by its ability to do better than
chance. The  statistic focuses on the possible scope for
distinguishing groups beyond chance, indicating the at-
tained proportion of this range (40). Arbitrarily, agree-
ment is considered very good when  is greater than 0.8,
good when  is between 0.8 and 0.6, moderate when  is
between 0.6 and 0.4, fair when  is between 0.4 and 0.2,
and poor when  is less than 0.2 (40). Our finding that 
for the group as a whole was 0.31 further strengthens our
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observation that the classifications of pattern B according
to GGE and NMR are not equivalent.
Care has to be taken when comparing  between sub-
groups with different underlying distributions (41). How-
ever, because the differences in  across subgroups in our
study follow the same pattern as differences in Spearman’s
rho for the continuous variables, we feel it is important to
highlight them. We found that agreement differed consid-
erably in subgroups of patients, being highest in nondia-
betic control subjects. Even in this group, which is a
sample of the general population,  was only 0.47. Our
finding of poor agreement in diabetic subjects, women,
and individuals in the lowest two tertiles of triglycerides
(1.30 mmol/l) indicates that the assumption of inter-
changeability can lead to considerable misclassification of
individuals in these groups. In clinical practice, LDL size
will mostly be measured in individuals with high triglycer-
ides, limiting the practical problems according to this sub-
division. Lower agreement in women and patients with
diabetes, however, remained even when analyses were re-
peated in the highest tertile of triglycerides, making our
findings relevant to clinical practice in these subgroups.
External validation
External validation revealed that LDL size according to
GGE was inversely related to CETP-catalyzed CET at a sta-
tistically significant level both for the group as a whole
and in subgroups according to gender and the presence
of diabetes. In the case of NMR, relations with CET were
only present in men and in subjects without diabetes. For
the group as a whole, no relation was found between CET
and NMR-based LDL size. Based on the metabolic func-
tions of CETP, a strong relation with LDL size was ex-
pected a priori. Previously, a correlation of 0.79 was re-
ported between CETP activity and LDL size on GGE (31).
The absence of a relation between LDL size on NMR and
CET in the same subgroups in which agreement between
NMR and GGE is lower confirms the findings of the agree-
ment analyses and indicates that mechanisms of choles-
teryl ester transfer, or other pathways determining lipo-
protein particle composition, might differ specifically in
these subgroups. As we hypothesized earlier (22), it is pos-
sible that potentially important compositional differences
in diabetic subjects and in women are not captured by the
current method of NMR-derived size. This might explain
why we previously found that NMR-defined particle size is
associated with coronary artery calcification in nondia-
betic subjects but not in type 1 diabetes (22). In the case
of GGE, LDL size was also related to coronary artery calci-
fication in nondiabetic subjects but not in diabetic sub-
jects. Spearman correlations were 0.31 (95% CI  0.44,
0.17) and 0.10 (95% CI  0.25, 0.06), respectively.
These relations were stronger for GGE than those previ-
ously reported for NMR (22).
Further exploration
Despite the differences in agreement between NMR
and GGE, the question remains regarding which measure
best predicts cardiovascular risk. An association between
small LDL and the occurrence of future cardiovascular
events has been found with both NMR (6, 7) and GGE
(2–5). However, in one study using GGE (2) and in both
studies using NMR (6, 7), the relation was abolished by
adjustment for cardiovascular risk factors. No study to
date has compared the predictive value of both methods
in a single population.
Our study has shown that the relation between LDL
peak size according to GGE and LDL average size accord-
ing to NMR is markedly lower in women compared with
men and in subjects with type 1 diabetes mellitus com-
pared with controls. From a research point of view, these
findings are of importance for the choice of methods in
studies of lipid metabolism. From a clinical point of view,
the observation that agreement in pattern B classification
is moderate at best means that the two methods should
not be considered interchangeable in individual risk as-
sessment in these important subgroups. Deciding which
method is better in cardiovascular risk assessment re-
quires a comparative analysis with prospective data, which
has not been undertaken to date.
This study was supported by a project grant from the British
Heart Foundation (PG97/160).
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